A biotech startup in Japan, Toregem Biopharma, is pioneering tooth regrowth by targeting a type of protein to enable natural tooth formation. Phase 1 clinical trials, set to begin in September, will test the safety of this groundbreaking treatment. Here’s everything you need to know about this exciting and much awaited developement.